NCT04827251View on ClinicalTrials.gov

Effects of Espresso on Platelet Aggregability in Patients with Coronary Artery Disease

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

November 25, 2024

Study Completion Date

November 25, 2024

Conditions
Coronary Artery Disease
Interventions
DIETARY_SUPPLEMENT

Coffee

"Participants will receive Nespresso coffee maker Essenza model. The coffee Nespresso blend voluto will be provided (caffeinated and decaffeinated). The patients will have to take four cups of espresso per day (three cups a day for patients aged 65 and over)."

Trial Locations (1)

05403-000

Heart Institute (InCor) / University of São Paulo, São Paulo

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

University of Sao Paulo

OTHER